Girard Sharp served as co-lead counsel in a certified securities class action on behalf of investors of Maxar Technologies, Ltd. (NYSE: MAXR) regarding alleged violations of federal securities laws for material misstatements and omissions associated with the performance and economic outlook of one of its core business units. The court granted preliminary approval of a $36.5 million settlement in June 2023.

Girard Sharp served as co-lead counsel in the certified product defect class action against Apple on behalf of purchasers of MacBook laptops equipped with Apple’s allegedly defective butterfly keyboard. The court granted final approval of a $50 million settlement in May 2023.

Girard Sharp represents IVF patients of Pacific Fertility Center whose eggs and embryos were damaged or destroyed in a cryopreservation tank failure. On June 11, 2021, after a three-week trial, a jury found the tank manufacturer, Chart Industries Inc., liable for a defect in the tank and for its negligent failure to recall a part that malfunctioned, a “controller” meant to monitor liquid nitrogen levels. The jury awarded more than $14 million in damages to three women who lost eggs and a married couple who lost embryos in the catastrophic March 2018 tank failure. The three women were each awarded between $2 million and $3 million, and the couple was awarded $7.2 million. Girard Sharp represents over 80 families who lost reproductive material in the tank failure.